{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:16:58Z","timestamp":1788405418876,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eprac.2026.08.005","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:50:05Z","timestamp":1786492205000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early Consideration of Automated Insulin Delivery in Type 2 Diabetes: A Critical Review"],"prefix":"10.1016","author":[{"given":"Zunera","family":"Tariq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Aleppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders L.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davida F.","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogish C.","family":"Kudva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Oser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth S.","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3827-7107","authenticated-orcid":false,"given":"Viral N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2026.08.005_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","article-title":"11th edition of the IDF diabetes atlas: Global, Regional, and National Diabetes Prevalence Estimates for 2024 and projections for 2050","volume":"14","author":"Genitsaridi","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2026.08.005_bib2","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc26-S001","article-title":"1. Improving care and promoting health in populations: standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.005_bib3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2337\/ds22-0084","article-title":"Therapeutic inertia and delays in insulin intensification in type 2 diabetes: a literature review","volume":"36","author":"Gavin","year":"2023","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.eprac.2026.08.005_bib4","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.2337\/dc26-S007","article-title":"7. Diabetes technology: standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.005_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clinthera.2018.12.014","article-title":"Clinical and economic outcomes of patients with type 2 diabetes on multiple daily injections of basal-bolus insulin (MDI) therapy: a retrospective cohort study","volume":"41","author":"Brixner","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.eprac.2026.08.005_bib6","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa2415948","article-title":"A randomized trial of automated insulin delivery in type 2 diabetes","volume":"392","author":"Kudva","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eprac.2026.08.005_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.59348","article-title":"Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial","volume":"8","author":"Pasquel","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eprac.2026.08.005_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/dia.2024.0586","article-title":"Safety and effectiveness of MiniMed(TM) 780G advanced hybrid closed-loop insulin intensification in adults with insulin-requiring type 2 diabetes","volume":"27","author":"Bhargava","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2026.08.005_bib9","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc26-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"Suppl 3","key":"10.1016\/j.eprac.2026.08.005_bib10","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.S16","article-title":"Five stages of evolving beta-cell dysfunction during progression to diabetes","volume":"53","author":"Weir","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.eprac.2026.08.005_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-8587(25)00333-X","article-title":"Staging prediabetes and type 2 diabetes: the time to start is now","volume":"14","author":"Shah","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2026.08.005_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MED.0000000000000166","article-title":"Diabetes in India: what is different?","volume":"22","author":"Shah","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.eprac.2026.08.005_bib13","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00125-021-05459-7","article-title":"Comparison of the contributions of impaired beta cell function and insulin resistance to the development of type 2 diabetes in a Japanese community: the Hisayama study","volume":"64","author":"Yoshinari","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.eprac.2026.08.005_bib14","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","article-title":"U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease","volume":"44","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.eprac.2026.08.005_bib15","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes study","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2026.08.005_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1900\/RDS.2006.3.208","article-title":"The fate of beta-cells in type 2 diabetes and the possible role of pharmacological interventions","volume":"3","author":"Gallwitz","year":"2006","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.eprac.2026.08.005_bib17","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2337\/dc24-0491","article-title":"Effect of semaglutide on regression and progression of glycemia in people with overweight or obesity but without diabetes in the SELECT trial","volume":"47","author":"Kahn","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.005_bib18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2410819","article-title":"Tirzepatide for obesity treatment and diabetes prevention","volume":"392","author":"Jastreboff","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eprac.2026.08.005_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S2213-8587(25)00022-1","article-title":"Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program Randomised Clinical Trial","volume":"13","author":"Knowler","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2026.08.005_bib20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2337\/dci26-0010","article-title":"Merging T1D and T2D management: shared strategies for common goals-building on early lessons from GLP-1 trials in T1D","volume":"49","author":"Bergenstal","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.005_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.diabres.2016.10.003","article-title":"Attitudes towards insulin initiation in type 2 diabetes patients among healthcare providers: a survey research","volume":"122","author":"Escalada","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.eprac.2026.08.005_bib22","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.2337\/dc13-0331","article-title":"Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people","volume":"36","author":"Khunti","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.005_bib23","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.2337\/dc26-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.005_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/dom.13088","article-title":"Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review","volume":"20","author":"Khunti","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2026.08.005_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s13300-020-00993-w","article-title":"A retrospective analysis of therapeutic inertia in type 2 diabetes management across a diverse population of health care organizations in the USA","volume":"12","author":"Rattelman","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.eprac.2026.08.005_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/cd20-0080","article-title":"Prevalence of and characteristics associated with overbasalization among patients with type 2 diabetes using basal insulin: a cross-sectional study","volume":"39","author":"Cowart","year":"2021","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.eprac.2026.08.005_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1080\/07853890.2021.1925148","article-title":"Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care","volume":"53","author":"Mehta","year":"2021","journal-title":"Ann Med"},{"key":"10.1016\/j.eprac.2026.08.005_bib28","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/dia.2021.0164","article-title":"Missed and mistimed insulin doses in people with diabetes: a systematic literature review","volume":"23","author":"Robinson","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2026.08.005_bib29","first-page":"1420","article-title":"Persistence with basal-bolus insulin therapy in patients with type 2 diabetes mellitus and effect on clinical and economic outcomes: a retrospective claims database study","volume":"25","author":"Edelman","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.eprac.2026.08.005_bib30","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s13300-024-01598-3","article-title":"Addressing the burden of multiple daily insulin injections in type 2 diabetes with insulin pump technology: a narrative review","volume":"15","author":"Brixner","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.eprac.2026.08.005_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2337\/cd19-0067","article-title":"Patients with type 2 diabetes are willing to do more to overcome therapeutic inertia: results from a double-blind survey","volume":"38","author":"Edelman","year":"2020","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.eprac.2026.08.005_bib32","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s12325-019-01199-8","article-title":"Evaluation of the clinical and economic burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the United States","volume":"37","author":"Ali","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.eprac.2026.08.005_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/dia.2023.0365","article-title":"Shining the spotlight on multiple daily insulin therapy: real-World evidence of the InPen smart insulin pen","volume":"26","author":"MacLeod","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2026.08.005_bib34","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s00125-024-06158-9","article-title":"Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes","volume":"67","author":"Trevisan","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.eprac.2026.08.005_bib35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2337\/dc24-2661","article-title":"Comparison of insulin titration strategies for glycemic control in type 2 diabetes: a systematic review and network meta-analysis","volume":"48","author":"Boonpattharatthiti","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.005_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/diabetology6020013","article-title":"Prescribed total daily insulin dose and predictors of insulin dose for adults with type 2 diabetes on multiple daily injections of insulin: a retrospective cohort study","volume":"6","author":"Wright","year":"2025","journal-title":"Diabetology"},{"key":"10.1016\/j.eprac.2026.08.005_bib37","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.2337\/dc25-2435","article-title":"Automated insulin delivery systems in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"49","author":"Hespanhol","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.005_bib38","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1111\/dom.70708","article-title":"Efficacy and safety of automated insulin delivery in people with type 2 diabetes: a systematic review and meta-analysis","volume":"28","author":"Di Molfetta","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2026.08.005_bib39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2337\/dc22-1692","article-title":"Simplified meal announcement versus precise carbohydrate counting in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed loop system: a randomized controlled trial comparing glucose control","volume":"46","author":"Petrovski","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.005_bib40","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/15209156251362700","article-title":"A retrospective real-life study to compare glycemic control between simplified meal size estimation and precise carbohydrates counting in type 1 diabetes patients using DBLG1 hybrid closed-loop system","volume":"27","author":"Blervaque","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2026.08.005_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00125-024-06319-w","article-title":"Simplified meal announcement study (SMASH) using hybrid closed-loop insulin delivery in youth and young adults with type 1 diabetes: a randomised controlled two-centre crossover trial","volume":"68","author":"Laesser","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.eprac.2026.08.005_bib42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/15209156251395035","article-title":"Simplified meal bolus strategies with Control-IQ+ automated insulin delivery are safe and effective in adults with type 2 diabetes","volume":"28","author":"Levy","year":"2026","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2026.08.005_bib52","doi-asserted-by":"crossref","first-page":"113450","DOI":"10.1016\/j.diabres.2026.113450","article-title":"Simplifying meal bolusing with Omnipod 5: real-world outcomes to support simplified user-initiated insulin dosing strategies in managing type 1 or type 2 diabetes","volume":"239","author":"Davis","year":"2026","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.eprac.2026.08.005_bib43","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/dia.2018.0266","article-title":"Temporary reductions in insulin requirements are associated with hypoglycemia in type 2 diabetes","volume":"20","author":"Harper","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2026.08.005_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/20420188241288789","article-title":"Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled clinical trial in patients with type 1 diabetes","volume":"15","author":"Nattero-Ch\u00e1vez","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.08.005_bib45","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/jamia\/ocaa238","article-title":"Building the evidence-base to reduce electronic health record-related clinician burden","volume":"28","author":"Dymek","year":"2021","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.eprac.2026.08.005_bib46","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.37765\/ajmc.2025.89725","article-title":"The role of advanced technologies in improving diabetes outcomes","volume":"31","author":"Marrero","year":"2025","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.eprac.2026.08.005_bib47","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/19322968251318373","article-title":"Performance of an automated insulin delivery system in people living with type 2 diabetes and insulin resistance: first real-world evidence in 26,427 users","volume":"20","author":"Thijs","year":"2026","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.eprac.2026.08.005_bib48","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1089\/dia.2022.0206","article-title":"Real-World evidence supporting Tandem Control-IQ hybrid closed-loop success in the medicare and medicaid type 1 and type 2 diabetes populations","volume":"24","author":"Forlenza","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2026.08.005_bib49","doi-asserted-by":"crossref","DOI":"10.2337\/db25-130-OR","article-title":"130-OR: real-World glycemic outcomes in adults with type 2 diabetes (T2D) using the omnipod 5 automated insulin delivery (AID) system","volume":"74","author":"Oser","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.eprac.2026.08.005_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2337\/cd19-0014","article-title":"Key features of insulin delivery devices for type 2 diabetes: type 2.0 booth survey","volume":"38","author":"Sze","year":"2020","journal-title":"Clin Diabetes"},{"issue":"2_suppl","key":"10.1016\/j.eprac.2026.08.005_bib51","first-page":"278","article-title":"Knowledge and attitudes regarding insulin pump use among adults with type 2 diabetes in the United States","volume":"26","author":"Polonsky","year":"2024","journal-title":"Diabetes Technol Ther"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:06:46Z","timestamp":1788404806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26011055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"alternative-id":["S1530891X26011055"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.005","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Consideration of Automated Insulin Delivery in Type 2 Diabetes: A Critical Review","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}